Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies

BACKGROUND: The Oncotype DX® Prostate Cancer Assay is a multi-gene RT-PCR expression assay that was developed for use with fixed paraffin-embedded (FPE) diagnostic prostate needle biopsies containing as little as 1 mm of prostate tumor in the greatest dimension. The assay measures expression of 12 c...

Descripción completa

Detalles Bibliográficos
Autores principales: Knezevic, Dejan, Goddard, Audrey D, Natraj, Nisha, Cherbavaz, Diana B, Clark-Langone, Kim M, Snable, Jay, Watson, Drew, Falzarano, Sara M, Magi-Galluzzi, Cristina, Klein, Eric A, Quale, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Methodology Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007703/
https://www.ncbi.nlm.nih.gov/pubmed/24103217
http://dx.doi.org/10.1186/1471-2164-14-690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007703/
https://www.ncbi.nlm.nih.gov/pubmed/24103217
http://dx.doi.org/10.1186/1471-2164-14-690

Ejemplares similares